<DOC>
	<DOCNO>NCT02492828</DOCNO>
	<brief_summary>This retrospective cohort study use national register linkage data ( include prescription , inpatient , mortality , socioeconomic data ) . The study period May 29 , 2013 June 30 , 2015 . Patients follow start treatment ( index date ) death , exit database , end study period ( June 30 , 2015 ) .</brief_summary>
	<brief_title>Adherence Apixaban Warfarin Patients With Arterial Fibrillation Real-world Setting Sweden</brief_title>
	<detailed_description />
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>For AF cohort Patients â‰¥1 AF diagnosis register patient register Apixaban subcohort 1 Patients eligible AF cohort Patients first prescription apixaban identification period without previous prescription NOACs warfarin precede 12 month Warfarin subcohort 1 Patients eligible AF cohort Patients first prescription warfarin identification period without previous prescription NOACs warfarin precede 12 month Apixaban subcohort 2 Patients eligible AF cohort Patients first prescription apixaban For AF cohort : Patients valvular AF exclude ( see definition Appendix 1 ) Warfarin subcohort 1 : Patients exclude subcohort least one prescription warfarin NOACs 12month period precede first prescription warfarin identification period , ie , index date</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>